LOS ANGELES CAPITAL MANAGEMENT LLC
Position in DNLI — Denali Therapeutics Inc.
CIK 1177206
LOS ANGELES, CA
Position in DNLI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$16,126
-$1,672 QoQ
Shares Held
627
-32.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#227
of 290 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. DNLI ranks #131 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in DNLI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,126 | 627 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $17,798 | 927 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $10,351 | 627 | Shares | Sole | 2026-02-11 | |
| 2024-12-31 | $452,884 | 22,222 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $813,892 | 27,940 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,227,478 | 52,863 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,141,158 | 55,612 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $999,134 | 46,558 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $949,021 | 46,002 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,326,651 | 44,956 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $426,401 | 18,507 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $581,284 | 20,902 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,311,721 | 42,741 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $1,292,536 | 43,919 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,359,246 | 42,252 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,832,703 | 41,092 | Shares | Sole | 2022-02-03 | |
| 2021-06-30 | $2,622,406 | 33,432 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $969,272 | 16,975 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $1,765,325 | 21,076 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $324,297 | 9,051 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $383,978 | 15,880 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $351,075 | 20,050 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||